This review outlines the pathophysiology, peripartum risk, and anesthetic management of pregnant patients with acquired cardiac disease.
Answers are grounded in this paper and cite their sources.
Informs peripartum anesthetic decisions in acquired cardiac disease; leaves open the need for prospective validation.
Physiologic changes incurred by pregnancy can cause severe decompensation in the parturient with underlying cardiac disease. The result is increased morbidity and mortality for both mother and child. Appropriate anesthetic management can significantly impact these outcomes. This review systematically presents the pathophysiology, peripartum risk, and anesthetic management in the puerperium of specific acquired cardiac abnormalities including: valvular disease, pulmonary hypertension, cardiomyopathy, cardiac transplantation, ischemia, arrhythmias, and cardiac arrest.
No takes yet. Share an insight, caveat, or question.
Wolff et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: